Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
O'Brien (Part A: uninfected household contacts), 2021 | randomized controlled trial | < Study carried out before the release of the omicron variant > |
O'Brien MP et al. medrxiv;2021.06.14.21258569v1 10.1101/2021.06.14.21258569 O'Brien MP et al. New England Journal of Medicine 10.1056/NEJMoa2109682 |
||
O'Brien (Part B: recently infected asymptomatic patients), 2021 | randomized controlled trial |
O'Brien MP et al. medrxiv;2021.06.14.21258569v1 10.1101/2021.06.14.21258569 |
|||
Isa, 2021 | randomized controlled trial | other | Phase I: multiple-dose administration of REGEN-COV. |